Author details

Full Name

Rafi Ahmed

Affiliation

ORCID

Career Start Year

1977

Papers

516

H Index

139

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37167972	Molecular basis of SARS-CoV-2 Omicron variant evasion from shared neutralizing antibody response.		2023
35639875	Risk Factors for Ebola Virus Persistence in Semen of Survivors in Liberia.	Clin Infect Dis	2023
36378537	mTOR regulates T cell exhaustion and PD-1-targeted immunotherapy response during chronic viral infection.	Journal of Clinical Investigation	2023
37756164	Reciprocal transmission of activating and inhibitory signals and cell fate in regenerating TÂ cells.		2023
37938974	The evolution and determinants of neutralization of potent head-binding antibodies against Ebola virus.		2023
37822504	Infants and young children generate more durable antibody responses to SARS-CoV-2 infection than adults.		2023
37645980	Mechanical force regulates ligand binding and function of PD-1.		2023
37708028	Light chain of a public SARS-CoV-2 class-3 antibody modulates neutralization against Omicron.		2023
37782797	Characteristics and anatomic location of PD-1TCF1 stem-like CD8 T cells in chronic viral infection and cancer.		2023
37624909	PD-1 blockade increases the self-renewal of stem-like CD8 T cells to compensate for their accelerated differentiation into effectors.		2023
37552991	mRNA vaccination boosts S-specific TÂ cell memory and promotes expansion of CD45RA T-like CD8 TÂ cells in COVID-19 recovered individuals.		2023
38055827	Mitochondrial metabolic flexibility is critical for CD8 T cell antitumor immunity.		2023
37863065	Longitudinal nucleocapsid antibody testing reveals undocumented SARS-CoV-2 infections in patients with lung cancer.	Cancer Cell	2023
37090559	Infants and young children generate more durable antibody responses to SARS-CoV-2 infection than adults.		2023
36511813	Impaired SARS-CoV-2 Variant Neutralization and CD8+ T-cell Responses Following 3 Doses of mRNA Vaccines in Myeloma: Correlation with Breakthrough Infections.	Blood Cancer Discov	2023
36950115	Cancer vaccines based on whole-tumor lysate or neoepitopes with validated HLA binding outperform those with predicted HLA-binding affinity.		2023
37191508	Efficacy of mRNA-1273 and Novavax ancestral or BA.1 spike booster vaccines against SARS-CoV-2 BA.5 infection in nonhuman primates.		2023
36622349	Low neutralizing activity of AZD7442 against current SARS-CoV-2 Omicron variants in patients with B-cell malignancies.		2023
37370724	Phenotype and Reactivity of Lymphocytes Expanded from Benign Prostate Hyperplasic Tissues and Prostate Cancer.		2023
36541799	Longitudinal Analysis of the Phenotype, Transcriptional Profile, and Anatomic Location of Memory CD8 T Cell Subsets after Acute Viral Infection.		2023
35196075	In vivo mRNA delivery to virus-specific T cells by light-induced ligand exchange of MHC class I antigen-presenting nanoparticles.	Science advances	2022
35765315	Mission, Organization, and Future Direction of the Serological Sciences Network for COVID-19 (SeroNet) Epidemiologic Cohort Studies.	Open Forum Infect Dis	2022
35584630	Distinct phenotypic states and spatial distribution of CD8 TÂ cell clonotypes in human brain metastases.	Cell Reports Medicine	2022
36171288	PD-1 combination therapy with IL-2 modifies CD8<sup>+</sup> T cell exhaustion program.	Nature	2022
36171284	PD-1-cis IL-2R agonism yields better effectors from stem-like CD8 T cells.	Nature	2022
36352100	Persistent intraocular Ebola virus RNA is associated with severe uveitis in a convalescent rhesus monkey.	Commun Biol	2022
35759727	Antibody Response to COVID-19 mRNA Vaccine in Patients With Lung Cancer After Primary Immunization and Booster: Reactivity to the SARS-CoV-2 WT Virus and Omicron Variant.	Journal of Clinical Oncology	2022
36350841	COVID-19 and the eye: Systemic and laboratory risk factors for retinopathy and detection of tear film SARS-CoV-2 RNA with a triplex RT-PCR assay.	PLoS One	2022
35820395	New epigenetic regulators of TÂ cell exhaustion.	Cancer Cell	2022
35567531	The Quest to Eradicate HPV-Related Oropharyngeal Carcinoma: An Opportunity Not to Miss.	Journal of the National Cancer Institute	2022
35436146	Humoral Responses Against SARS-CoV-2 and Variants of Concern After mRNA Vaccines in Patients With Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia.	Journal of Clinical Oncology	2022
35939675	PD-1 blockade following ART interruption enhances control of pathogenic SIV in rhesus macaques.	Proceedings of the National Academy of Sciences of the United States of America	2022
36197988	Structural insights for neutralization of Omicron variants BA.1, BA.2, BA.4, and BA.5 by a broadly neutralizing SARS-CoV-2 antibody.	Science advances	2022
35862190	Herpes simplex virus lymphadenitis is associated with tumor reduction in a patient with chronic lymphocytic leukemia.	J Clin Invest	2022
35480625	Pre-existing SARS-CoV-2 immunity influences potency, breadth, and durability of the humoral response to SARS-CoV-2 vaccination.	Cell Reports Medicine	2022
36324804	Molecular basis of SARS-CoV-2 Omicron variant evasion from shared neutralizing antibody response.		2022
35980386	TGF-Î² regulates the stem-like state of PD-1+ TCF-1+ virus-specific CD8 T cells during chronic infection.	J Exp Med	2022
35404084	Persistence of Virus-Specific Antibody after Depletion of Memory B Cells.	J Virol	2022
36644323	Antibody binding and neutralization of live SARS-CoV-2 variants including BA.4/5 following booster vaccination of patients with B-cell malignancies.		2022
34001528	Evolving Views of Long Noncoding RNAs and Epigenomic Control of Lymphocyte State and Memory.	Cold Spring Harb Perspect Biol	2022
35259002	Determinants of Neutralizing Antibody Response After SARS CoV-2 Vaccination in Patients With Myeloma.	Journal of Clinical Oncology	2022
35032866	Induction of thymic atrophy and loss of thymic output by type-I interferons during chronic viral infection.	Virology	2022
35018383	Antibody response to SARS-CoV-2 mRNA vaccine in lung cancer patients: Reactivity to vaccine antigen and variants of concern.		2022
35303429	Asymmetric and non-stoichiometric glycoprotein recognition by two distinct antibodies results in broad protection against ebolaviruses.	Cell	2022
34471285	Functional HPV-specific PD-1<sup>+</sup> stem-like CD8 T cells in head and neck cancer.	Nature	2021
34242561	Immunological lessons from CD28 deficiency in humans.	Cell	2021
33706207	Characterization of neutralizing versus binding antibodies and memory B cells in COVID-19 recovered individuals from India.	Virology	2021
33544838	Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine.	J Exp Med	2021
33798491	Infection- and vaccine-induced antibody binding and neutralization of the B.1.351 SARS-CoV-2 variant.		2021
33739374	Neutralizing Antibodies Against SARS-CoV-2 Variants After Infection and Vaccination.	JAMA	2021